Page 212 - 2021_05-Haematologica-web

M.V. Chan et al.
ciency. Am J Hematol. 1983;14(1):1-9.
46. Lagarde M, Byron PA, Vargaftig BB, Dechavanne M. Impairment of platelet thromboxane A 2 generation and of the platelet release reaction in two patients with congenital deficiency of platelet cyclo- oxygenase. Br J Haematol. 1978;38(2):251- 266.
47.Malmsten C, Hamberg M, Svensson J, Samuelsson B. Physiological role of an endoperoxide in human platelets: hemosta- tic defect due to platelet cyclo-oxygenase deficiency. Proc Natl Acad Sci. 1975;72(4):1446-1450.
48.Nyman D, Eriksson AW, Lehmann W, Blombäck M. Inherited defective platelet
aggregation with arachidonate as the main expression of a defective metabolism of arachidonic acid. Thromb Res. 1979;14(4– 5):739-746.
49. Pareti FI, Mannucci PM, D’Angelo A, Smith JB, Sautebin L, Galli G. Congenital deficien- cy of thromboxane and prostacyclin. Lancet. 1980;315(8174):898-901.
50. Nance D, Campbell RA, Rowley JW, et al. Combined variants in factor VIII and prostaglandin synthase-1 amplify hemor- rhage severity across three generations of descendants. J Thromb Haemost 2016; 14(11):2230-2240.
51.Leinøe E, Zetterberg E, Kinalis S, et al. Application of whole-exome sequencing to
direct the specific functional testing and diagnosis of rare inherited bleeding disor- ders in patients from the Öresund Region, Scandinavia. Br J Haematol. 2017; 179(2):308-322.
52.Yagmur E, Weiskirchen R, Schedel A, Bugert P. PTGS1 compound heterozygosity impairs gene expression and platelet aggre- gation and is associated with severe bleed- ing complications. Thromb Haemost. 2013;110(5):1083-1085.
53.Bastida JM, Lozano ML, Benito R, et al. Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders. Haematologica. 2018;103(1):148-162.
1432
haematologica | 2021; 106(5)